University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Biological: HSPPC-96
Drug: Temozolomide
Procedure: Standard Surgical Resection

First Posted Date: 2009-05-20

Last Posted Date: 2021-03-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 70

Registration Number: NCT00905060

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

and more 6 locations

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

Recruiting

Conditions: Inflammatory Bowel Disease

First Posted Date: 2009-05-20

Last Posted Date: 2023-07-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1500

Registration Number: NCT00904878

Locations: 🇺🇸
Please Contact Jessica Lim For Further Information Regarding Other Sites' Locations, San Francisco, California, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

Interscanner Variation in Musculoskeletal Computed Tomography (CT) Measures

Completed

Conditions: Accidental Falls
Loss of Muscle Strength

First Posted Date: 2009-05-11

Last Posted Date: 2010-06-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT00896415

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Drug: raltegravir
Drug: Study NNRTI
Drug: Study PI

First Posted Date: 2009-04-21

Last Posted Date: 2012-07-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 8

Registration Number: NCT00884793

Locations: 🇺🇸
San Francisco VA Medical Center (SFVAMC), San Francisco, California, United States
🇺🇸
San Francisco General Hospital, San Francisco, California, United States

Treating People With Post-Traumatic Stress Disorder With Cognitive Behavioral Therapy for Insomnia

Not Applicable

Completed

Conditions: Post-Traumatic Stress Disorder

Interventions: Other: Cognitive Behavioral Treatment for Insomnia (CBT-I)

First Posted Date: 2009-04-15

Last Posted Date: 2014-03-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 45

Registration Number: NCT00881647

Locations: 🇺🇸
VA Medical Center, San Francisco, San Francisco, California, United States

Pharmacogenetics of Nicotine Metabolism in African-Americans

Phase 1

Completed

Conditions: Cigarette Smoking

Interventions: Drug: Deuterated nicotine and cotinine

First Posted Date: 2009-04-13

Last Posted Date: 2013-05-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 70

Registration Number: NCT00879918

Locations: 🇺🇸
University of California San Francisco/SFGH, San Francisco, California, United States

Trial of Mental Health Treatment for Darfur Refugees in Cairo

Not Applicable

Completed

Conditions: Post-Traumatic Stress Disorder
Depression
Anger
Domestic Violence

Interventions: Behavioral: Interpersonal Therapy

First Posted Date: 2009-04-13

Last Posted Date: 2023-11-08

Lead Sponsor: University of California, San Francisco

Registration Number: NCT00879853

Locations: 🇪🇬
Ma'an Organization, Cairo, Egypt

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Phase 1

Completed

Conditions: HIV Infections
Hepatitis C

Interventions: Drug: Alcohol
Drug: Alcohol placebo

First Posted Date: 2009-04-09

Last Posted Date: 2014-05-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT00879047

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: epirubicin hydrochloride
Drug: panobinostat
Genetic: gene expression analysis
Genetic: protein expression analysis
Genetic: western blotting
Other: immunologic technique
Other: laboratory biomarker analysis
Other: pharmacological study

First Posted Date: 2009-04-09

Last Posted Date: 2017-03-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT00878904

Locations: 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Disulfiram Interactions With HIV Medications: Clinical Implications

Phase 1

Completed

Conditions: HIV Infections
Drug Abuse

Interventions: Drug: Disulfiram + Efavirenz
Drug: Disulfiram + Atazanavir
Drug: Disulfiram + Ritonavir
Drug: Disulfiram

First Posted Date: 2009-04-08

Last Posted Date: 2014-05-06

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT00878306

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy